Strength Seen in CVRx (CVRX): Can Its 19.0% Jump Turn into More Strength?

CVRx stock rallied following the company's announcement to appoint Robert John as Chief Revenue Officer effective June 27. CVRx management expects John's presence will help the company to expand the adoption of Barostim therapy. For CVRx, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CVRX going forward to see if this rec ...